CORC

在结果中检索

CORC

浏览/检索结果: 共10条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载：43/0  |  提交时间：2022/02/14
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma : a multicentre, single-arm, phase 2 trial 期刊论文
The Lancet Haematology, 2019, 卷号: Vol.6 No.1, 页码: e12-e19
作者:  Yuankai Shi;  Hang Su;  Yongping Song;  Wenqi Jiang;  Xiuhua Sun
收藏  |  浏览/下载：39/0  |  提交时间：2019/02/25
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文
2019
作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Clinical characteristics and prognostic factors in Chinese patients with classical Hodgkin's lymphoma involving extranodal sites: a retrospective single-center 期刊论文
2019, 卷号: 24, 期号: 1, 页码: 661-668
作者:  Zou Dong-Mei;  Zhou Dao-Bin;  Zhang Yan;  Wang Wei;  Zhang Wei
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31
MGCD0103 induces apoptosis and simultaneously increases the expression of NF-kappa B and PD-L1 in classical Hodgkin's lymphoma 期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 卷号: 16, 期号: 5
作者:  Huang, Renhong;  Zhang, Xiaowei;  Min, Zhijun;  Shadia, Abdelbari Sophia;  Yang, Shun'e
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer 期刊论文
BMC GENOMICS, 2015
Gnad, Florian; Doll, Sophia; Manning, Gerard; Arnott, David; Zhang, Zemin
收藏  |  浏览/下载：2/0  |  提交时间：2017/12/03

©版权所有 ©2017 CSpace - Powered by CSpace